EPO and anemia: Additionally, bone marrow erythroid hypoplasia is a feature of CRA and circulating erythropoietin (EPO) levels, the main erythrocyte growth factor, are inappropriately low in relation to the degree of anemia and intact renal function (Adamson, 2008).